More information: Mengting Jiang et al, Structural basis of the cysteinyl leukotriene receptor type 2 activation by LTD4, Proceedings of the National Academy of Sciences (2025). DOI: 10.1073/pnas.

Th2 cells also release IL-9 to further activate mast cells, causing them to release histamine, PGD2, leukotrienes, cysteinyl, and cytokines ... may indicate the presence of type 2 inflammation: (1) A ...

Proportion of adult managed care organizations with availability varied from 24 to 100 percent for SGLT2 inhibitors, 0 to 99 percent for GLP-1 receptor agonists. (HealthDay News) — Many Medicaid ...

Many Medicaid enrollees with type 2 diabetes have restricted access to cardioprotective medications, including sodium-glucose cotransporter-2 inhibitors (SGLT2is) and glucagon-like peptide-1 receptor ...

NEW research presented at WCO 2025 has raised concerns about the long-term skeletal safety of GLP-1 receptor agonists (GLP-1 RAs), a class of drugs widely used to manage type 2 diabetes and, more ...

WEDNESDAY, April 30, 2025 (HealthDay News) — Many Medicaid enrollees with type 2 diabetes have restricted access to cardioprotective medications, including sodium-glucose cotransporter-2 inhibitors ...

NEW YORK--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) today announced the decision to discontinue development of danuglipron (PF-06882961), an oral glucagon-like peptide-1 (GLP-1) receptor agonist ...

Novo Nordisk's GLP-1 receptor agonist semaglutide has been shown to help people struggling with alcohol use disorder (AUD) reduce the amount they drink – pointing to yet another potential use ...

The researchers found that while most glucose-lowering therapies were not significantly associated with a reduction in dementia risk, one class of drugs—known as GLP-1 receptor agonists (GLP ...